Search results for: 'Global Precision Oncology Market Trends and Growth Opportunities'

The procedure for accurately identifying a biomarker correlation based on a patient s genetic makeup is complex and relies on the expertise and knowledge of an oncologist, decision-support scientist, or other healthcare professional involved in the matching process. Precision oncology aims to provide oncologists with diagnosis, prognosis, and treat...

Cardiometabolic diseases, including cardiovascular disease (which encompasses coronary artery diseases, chronic/congestive heart failure, stroke, and hypertension), type 2 diabetes, and obesity, have been increasing globally. As a result, the healthcare cost burden has become significant and is anticipated to rise further. Existing drug therapies f...

This research service offers a comprehensive analysis of the global oncology biomarker diagnostics market, which has transformed with the convergence of clinical demand, advances in technology, and strategic collaborations/partnerships coupled with precision medicine initiatives. It categorizes the market by technology (omics, immunoassays, bioinfo...

Cardiovascular diseases (CVDs) remain the leading cause of global morbidity and mortality, with reported cases having doubled since 1990. Today, CVDs account for 1 in 3 deaths worldwide, representing 32% of total global mortality, with heart attacks and ischemic strokes responsible for approximately 85% of these outcomes. The rising burden is stron...

Immuno-oncology (I-O) therapies target tumors by harnessing the host s immune system. With the growing incidence and prevalence of various types of aggressive and refractory cancers, the next-generation I-O therapy pipeline has witnessed significant growth. Chimeric antigen receptor (CAR)-T cell therapy and tumor-targeted antibody therapies, includ...

31 Jul 2023  |  North America  |  Market Research

Global Oncology Diagnostics in IVD Growth Opportunities

By Leveraging Data-driven Solutions, Co-development Opportunities, and Assay Innovation, Clients Can Experience Enhanced Product Performance, Cost-effectiveness, and Improved Decision-making Capabilities

Infographics

×

The global oncology diagnostics in IVD market is expected to witness significant growth, driven by an increase in cancer incidence, technological developments in diagnostic tests, the growing number of screening tests, and supportive government initiatives. Owing to the intense competition in the market, the most prominent companies are investing h...

The global ground tactical precision-guided munitions (PGM) market is undergoing a profound transformation, as modern land warfare shifts toward accuracy, agility, and lethality. Military doctrines worldwide are evolving to prioritize precise, low-collateral effects and decentralized firepower at the tactical edge, especially within infantry and ma...

Advanced visualization and robotic tools during the pre-operative and intraoperative phases of a procedure allow surgeons to identify and localize targets so that they can navigate and perform complex surgeries with precision, minimizing invasiveness, improving recovery times, and lowering the risk of post-procedure complications. This Frost & ...

This edition of the Life Science, Health & Wellness Technology Opportunity Engine (TOE) provides actionable insights across new developments in oncology, immunology, autoimmune disorders, and precision medicine, highlighting next-generation biologics, bispecific antibodies, kinase inhibitors, molecular glues, and antibody engineering platforms. The...